31 March 2019

The Association of European Cancer Leagues’ (ECL) Access to Medicines Task Force calls on the health community to join forces and bring more transparency and accountability to the pharmaceutical system, to set fair prices of innovative medicines and ultimately improve access to high quality cancer treatments for all cancer patients in Europe. Because affordability is everyone’s problem.